Loading...

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

BACKGROUND: Dose-dense sequential chemotherapy including anthracyclines and taxanes has been established in the adjuvant setting of high-risk operable breast cancer. However, the preferable taxane and optimal schedule of administration in a dose-dense regimen have not been defined yet. METHODS: From...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Cancer
Main Authors: Fountzilas, George, Dafni, Urania, Papadimitriou, Christos, Timotheadou, Eleni, Gogas, Helen, Eleftheraki, Anastasia G, Xanthakis, Ioannis, Christodoulou, Christos, Koutras, Angelos, Papandreou, Christos N, Papakostas, Pavlos, Miliaras, Spyros, Markopoulos, Christos, Dimitrakakis, Constantine, Korantzopoulos, Panagiotis, Karanikiotis, Charisios, Bafaloukos, Dimitrios, Kosmidis, Paris, Samantas, Epaminontas, Varthalitis, Ioannis, Pavlidis, Nicholas, Pectasides, Dimitrios, Dimopoulos, Meletios-Athanassios
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223601/
https://ncbi.nlm.nih.gov/pubmed/25026897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-515
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!